Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow Quality Index
Binh Dinh Pharmaceutical and Medical Equipment JSC cash flow quality index. Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow Quality Index of -1.69x as of March 2026. Operating cash flow of ₫-135.66 Billion is below net income of ₫80.30 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore DBD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Binh Dinh Pharmaceutical and Medical Equipment JSC (2019–2025)
Cash flow quality index of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2019 to 2025. Historical Cash Flow Quality Index for Binh Dinh Pharmaceutical and Medical Equipment JSC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. See DBD net asset quality index to measure how much of total assets are equity-financed.
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow Quality Index by Year (2019–2025)
Binh Dinh Pharmaceutical and Medical Equipment JSC cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Binh Dinh Pharmaceutical and Medical Equipment JSC. For the full cash flow conversion analysis, see Binh Dinh Pharmaceutical and Medical Equ cash flow conversion.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.11x | ₫615.19 Billion | ₫291.94 Billion | ▲ +119.0% |
| 2024 | 0.96x | ₫264.73 Billion | ₫275.18 Billion | ▼ -11.9% |
| 2023 | 1.09x | ₫293.99 Billion | ₫269.28 Billion | ▲ +61.1% |
| 2022 | 0.68x | ₫165.01 Billion | ₫243.56 Billion | ▲ +5.9% |
| 2021 | 0.64x | ₫117.57 Billion | ₫183.79 Billion | ▼ -52.6% |
| 2020 | 1.35x | ₫212.91 Billion | ₫157.86 Billion | ▲ +18612.7% |
| 2019 | -0.01x | ₫-1.04 Billion | ₫142.23 Billion | — |